Innova Captab Quarterly Results for Trading Insights
INNOVACAP • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹30 Cr
QSept 2025
Innova Captab Quarterly Results Key Highlights
- Revenue of ₹385 Cr in Sept 2025 (+21.1% vs Mar 2025, +20.3% vs Sept 2024)
- Net Profit of ₹30 Cr in Sept 2025 (+0.0% vs Mar 2025, -14.3% vs Sept 2024)
- EBITDA of ₹56 Cr in Sept 2025 (+9.8% vs Mar 2025)
- Operating Margin of 14.0% in Sept 2025 (-1.0pp vs Mar 2025)
- Earnings Per Share of ₹5.18 in Sept 2025 (+0.2% vs Mar 2025)
Innova Captab Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 385 | 318 | 356 | 320 | 268 | 21.1% | 20.3% |
| Net Profit (₹ Cr) | 30 | 30 | 31 | 35 | 29 | - | - |
| EBITDA (₹ Cr) | 56 | 51 | 57 | 52 | 44 | - | - |
| EPS (₹) | 5.18 | 5.17 | 5.42 | 6.12 | 5.02 | - | - |
| Operating Margin (%) | 14.0% | 15.0% | 15.0% | 16.0% | 15.0% | - | - |
Innova Captab Share Price Trend Around Quarterly Results
Visualize Innova Captab's 1-year price movement across quarterly results — ideal for logging trades in Innova Captab share price
chart using Tickjournal. All values in ₹.
Related Pages for Innova Captab
Additional stock information and data for INNOVACAP
Revenue Trend (₹ Cr)
Sept 2024
320
Jun 2025
356
Mar 2025
318
Sept 2025
385
Net Profit Trend (₹ Cr)
Sept 2024
35
Jun 2025
31
Mar 2025
30
Sept 2025
30
Operating Margin Trend (%)
Sept 2024
16.0%
Jun 2025
15.0%
Mar 2025
15.0%
Sept 2025
14.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Innova Captab quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹412,613.60 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,570.84 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores